Evidence map›Paper›PMID 26420874›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection.

Simon J F Harper, Jason M Ali, Elizabeth Wlodek, Marg C Negus, Ines G Harper, Manu Chhabra, M Saeed Qureshi, Mekhola Mallik, Eleanor Bolton, J Andrew Bradley and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 108 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Unraveling CD8American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Review
  12. Article
  13. Extracellular Vesicles and Immune Activation in Solid Organ Transplantation: The Impact of Immunosuppression.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2025
    Review
  14. Graft-derived extracellular vesicles transport miRNAs to modulate macrophage polarization after heart transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
  15. Adenosine triphosphate-mediated signaling of P2X7 receptors controls donor extracellular vesicle release and major histocompatibility complex cross-decoration after allotransplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Simon J F HarperSchool of Clinical Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom.
Jason M AliSchool of Clinical Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom ja297@cam.ac.uk gjp25@cam.ac.uk.
Elizabeth WlodekSchool of Clinical Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom.
Marg C NegusSchool of Clinical Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom.
Ines G HarperSchool of Clinical Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom.
Manu ChhabraSchool of Clinical Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom.
M Saeed QureshiSchool of Clinical Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom.
Mekhola MallikSchool of Clinical Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom.
Eleanor BoltonSchool of Clinical Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom.
J Andrew BradleySchool of Clinical Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom.
Gavin J PettigrewSchool of Clinical Medicine, University of Cambridge, Cambridge, CB2 0QQ, United Kingdom ja297@cam.ac.uk gjp25@cam.ac.uk.
University of Cambridge · GB

Funding

British Heart Foundation FS/10/018/28193British Heart Foundation FS/12/87/29899British Heart Foundation PG/10/002/28143Wellcome Trust
6 · The paper itself

Abstract

Adaptive CD8 T-cell immunity is the principal arm of the cellular alloimmune response, but its development requires help. This can be provided by CD4 T cells that recognize alloantigen "indirectly," as self-restricted allopeptide, but this process remains unexplained, because the target epitopes for CD4 and CD8 T-cell recognition are "unlinked" on different cells (recipient and donor antigen presenting cells (APCs), respectively). Here, we test the hypothesis that the presentation of intact and processed MHC class I alloantigen by recipient dendritic cells (DCs) (the "semidirect" pathway) allows linked help to be delivered by indirect-pathway CD4 T cells for generating destructive cytotoxic CD8 T-cell alloresponses. We show that CD8 T-cell-mediated rejection of murine heart allografts that lack hematopoietic APCs requires host secondary lymphoid tissue (SLT). SLT is necessary because within it, recipient dendritic cells can acquire MHC from graft parenchymal cells and simultaneously present it as intact protein to alloreactive CD8 T cells and as processed peptide alloantigen for recognition by indirect-pathway CD4 T cells. This enables delivery of essential help for generating cytotoxic CD8 T-cell responses that cause rapid allograft rejection. In demonstrating the functional relevance of the semidirect pathway to transplant rejection, our findings provide a solution to a long-standing conundrum as to why SLT is required for CD8 T-cell allorecognition of graft parenchymal cells and suggest a mechanism by which indirect-pathway CD4 T cells provide help for generating effector cytotoxic CD8 T-cell alloresponses at late time points after transplantation.

Indexed as

Heart TransplantationAllograftsAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDendritic CellsGraft RejectionHistocompatibility Antigens Class IIsoantigensMiceMice, Inbred BALB CMice, KnockoutHistocompatibility Antigens Class IIsoantigensalloimmunityallorecognitionCD8 cytotoxicitysemidirect allorecognitionsemidirect pathway

Identifiers

PMID26420874
PMCPMC4611606
OpenAlexW2146417328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.